CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be ...

The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth advocates argue that two of these rules hinder access to care.

The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. genAI engine on a ...

Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in ...

Healthcare organizations have to balance the need to support data collection with staff workloads. More healthcare practices are working with health tech vendors to digitize their workflows and ...

From record-high drug shortages to the explosive popularity of GLP-1 medications and the intensifying battle over the 340B drug discount program, many of the biggest healthcare stories of 2024 ...

Every healthcare system in the United States has its own level of vulnerability to cyberattacks. And each system, to the degree its resources and perception allow, is trying to eliminate those ...

In a new brief, the Purchaser Business Group on Health called for policy changes that address healthcare costs and improve access to high-quality care.

A drug that Novo Nordisk acquired to expand its prospects in metabolic disorders has failed a mid-stage clinical trial in diabetic kidney disease. The results also showed signs of a ...

Last year, more than 30 million American adults believed they had a substance use problem, while one out of five young people who suffered a major depressive episode also struggled with substance ...